(Q35353453)

7 August 2017

1 reference

title

Cholera as a model for research on mucosal immunity and development of oral vaccines (English)

1 reference

7 August 2017

0 references

1

Holmgren J

1 reference

7 August 2017

C. Czerkinsky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1388838

21 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1388838

21 September 2022

publication date

1 August 1992

1 reference

Current Opinion in Immunology

7 August 2017

published in

1 reference

7 August 2017

volume

4

1 reference

7 August 2017

issue

4

1 reference

7 August 2017

page(s)

387-391

1 reference

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Field trial of oral cholera vaccines in Bangladesh: serum vibriocidal and antitoxic antibodies as markers of the risk of cholera.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Biotype as determinant of natural immunising effect of cholera

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Surface co-expression of Vibrio cholerae and Salmonella typhi O-antigens on Ty21a clone EX210

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

In vivo evidence of immunological masking of the Vibrio cholerae O antigen of a hybrid Salmonella typhi Ty21a-Vibrio cholerae oral vaccine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

The early cellular and humoral immune response to primary and booster oral immunization with cholera toxin B subunit.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2806%2980027-0

7 January 2021

10.1016/S0952-7915(06)80027-0

Identifiers

DOI

1 reference

7 August 2017

1 reference